Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DUET 02

Next Previous
Drug Profile

DUET 02

Alternative Names: CpG-STAT3ASO; DUET-02; DUET-02A; DUET-101; OLIM-01

Latest Information Update: 01 Oct 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator City of Hope National Medical Center
  • Developer Scopus BioPharma
  • Class Antineoplastics; Antisense oligonucleotides; Immunotherapies
  • Mechanism of Action RNA interference; STAT3 transcription factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Head and neck cancer; Prostate cancer; Urogenital cancer

Most Recent Events

  • 01 Oct 2021 Pharmacodynamics data from a preclinical trial in Prostate cancer presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS-2021)
  • 29 Sep 2021 Preclinical trials in Prostate cancer in USA (Parenteral)
  • 27 Sep 2021 Scopus Biopharma plans a phase I trial for Head and neck cancer and Urogenital cancer in USA in Q1 of 2023

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top